JPC Global
Indian Pharmaceutical Exporter ยท Advanced Antibiotics Specialist ยท $286.9K Total Trade ยท DGFT Verified
JPC Global is an Indian pharmaceutical exporter with a total trade value of $286.9K across 6 products in 4 therapeutic categories. Based on 132 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ceftazidime ($186.2K), Antitoxin ($31.5K), Tofacitinib ($22.9K).
JPC Global โ Export Portfolio & Destination Treemap

Who is JPC Global? โ Company Overview & Market Position
JPC Global is an Indian pharmaceutical exporter specializing in the supply of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2015, the company is headquartered in New Delhi, India. It operates as a limited liability partnership (LLP) under the Corporate Identification Number (CIN) AAD-3675. The firm's ownership structure comprises two designated partners: Rajat Juneja and Chandar Prakash Juneja. As of the latest available data, JPC Global has a total obligation of contribution of โน10,000. The company has been active in the pharmaceutical industry for over eight years, focusing on the export of branded and contract-manufactured products. While specific revenue figures are not publicly disclosed, JPC Global has established a strong presence in the market, with a network of more than 300 distributors and authorized suppliers within India. The company's website, jpcglobal.co.in, provides further information on its products and services.